Tg Therapeutics, INC Form 4 insider transactions

Laurence N. Charney, a director at TG Therapeutics, acquired 22,250 shares of common stock through a grant on June 19, 2024.

Director Sagar Lonial sold 5,000 shares of TG Therapeutics (TGTX) common stock at a price of $15.935 on March 13, 2024.

Laurence N. Charney, a director of TG Therapeutics, sold 22,000 shares of common stock on March 12, 2024, to cover income tax obligations.